BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kulkarni AV, Kumar P, Tevethia HV, Premkumar M, Arab JP, Candia R, Talukdar R, Sharma M, Qi X, Rao PN, Reddy DN. Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19. Aliment Pharmacol Ther. 2020;52:584-599. [PMID: 32638436 DOI: 10.1111/apt.15916] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 29.5] [Reference Citation Analysis]
Number Citing Articles
1 Metawea MI, Yousif WI, Moheb I. COVID 19 and liver: An A-Z literature review. Dig Liver Dis. 2021;53:146-152. [PMID: 32988758 DOI: 10.1016/j.dld.2020.09.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
2 Kulkarni AV, Tevethia HV, Premkumar M, Arab JP, Candia R, Kumar K, Kumar P, Sharma M, Rao PN, Reddy DN. Impact of COVID-19 on liver transplant recipients-A systematic review and meta-analysis. EClinicalMedicine 2021;38:101025. [PMID: 34278287 DOI: 10.1016/j.eclinm.2021.101025] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
3 Mirzaie H, Vahidi M, Shokoohi M, Darvishian M, Sharifi H, Sharafi H, Karamouzian M. COVID-19 Among Patients With Hepatitis B or Hepatitis C: A Systematic Review. Hepat Mon 2021;20. [DOI: 10.5812/hepatmon.111617] [Reference Citation Analysis]
4 Kulkarni AV, Parthasarathy K, Kumar P, Sharma M, Reddy R, Chaitanya Akkaraju Venkata K, Gupta R, Gupta A, Swaroop S, Giri Vishwanathan P, Senapathy G, Menon PB, Reddy ND, Padaki NR. Early liver transplantation after COVID-19 infection: The first report. Am J Transplant 2021;21:2279-84. [PMID: 33508881 DOI: 10.1111/ajt.16509] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
5 Baroiu L, Dumitru C, Iancu A, Leșe AC, Drăgănescu M, Baroiu N, Anghel L. COVID-19 impact on the liver. World J Clin Cases 2021; 9(16): 3814-3825 [PMID: 34141738 DOI: 10.12998/wjcc.v9.i16.3814] [Cited by in CrossRef: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Licata A, Minissale MG, Distefano M, Montalto G. Liver injury, SARS-COV-2 infection and COVID-19: What physicians should really know? GastroHep 2021;3:121-30. [PMID: 34149320 DOI: 10.1002/ygh2.455] [Reference Citation Analysis]
7 Bzeizi K, Abdulla M, Mohammed N, Alqamish J, Jamshidi N, Broering D. Effect of COVID-19 on liver abnormalities: a systematic review and meta-analysis. Sci Rep 2021;11:10599. [PMID: 34012016 DOI: 10.1038/s41598-021-89513-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Elnaggar M, Abomhya A, Elkhattib I, Dawoud N, Doshi R. COVID-19 and liver diseases, what we know so far. World J Clin Cases 2022; 10(13): 3969-3980 [DOI: 10.12998/wjcc.v10.i13.3969] [Reference Citation Analysis]
9 Sivandzadeh GR, Askari H, Safarpour AR, Ejtehadi F, Raeis-Abdollahi E, Vaez Lari A, Abazari MF, Tarkesh F, Bagheri Lankarani K. COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges. World J Clin Cases 2021; 9(22): 6178-6200 [PMID: 34434987 DOI: 10.12998/wjcc.v9.i22.6178] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Idalsoaga F, Ayares G, Arab JP, Díaz LA. COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence. J Clin Transl Hepatol 2021;9:760-8. [PMID: 34722191 DOI: 10.14218/JCTH.2020.00140] [Reference Citation Analysis]
11 Chinnici CM, Russelli G, Bulati M, Miceli V, Gallo A, Busà R, Tinnirello R, Conaldi PG, Iannolo G. Mesenchymal stromal cell secretome in liver failure: Perspectives on COVID-19 infection treatment. World J Gastroenterol 2021; 27(17): 1905-1919 [PMID: 34007129 DOI: 10.3748/wjg.v27.i17.1905] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ghazanfar H, Kandhi S, Shin D, Muthumanickam A, Gurjar H, Qureshi ZA, Shaban M, Farag M, Haider A, Budhathoki P, Bhatt T, Ghazanfar A, Jyala A, Patel H. Impact of COVID-19 on the Gastrointestinal Tract: A Clinical Review. Cureus. [DOI: 10.7759/cureus.23333] [Reference Citation Analysis]
13 Xu Y, Yang X, Bian H, Xia M. Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management. Lipids Health Dis 2021;20:126. [PMID: 34602072 DOI: 10.1186/s12944-021-01564-z] [Reference Citation Analysis]
14 Kovalic AJ, Huang G, Thuluvath PJ, Satapathy SK. REPLY. Hepatology 2021;73:2080-1. [PMID: 32895966 DOI: 10.1002/hep.31542] [Reference Citation Analysis]
15 Kardani K, Bolhassani A, Kardani M, Agi E; Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran, Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran, Iranian Comprehensive Hemophilia Care Center, Tehran, Iran, Iranian Comprehensive Hemophilia Care Center, Tehran, Iran. Correlation of SARS-CoV-2 Infection with Hepatitis and Liver Disorders. JoMMID 2021;9:122-32. [DOI: 10.52547/jommid.9.3.122] [Reference Citation Analysis]
16 Rabaan AA, Al-Ahmed SH, Garout MA, Al-Qaaneh AM, Sule AA, Tirupathi R, Mutair AA, Alhumaid S, Hasan A, Dhawan M, Tiwari R, Sharun K, Mohapatra RK, Mitra S, Emran TB, Bilal M, Singh R, Alyami SA, Moni MA, Dhama K. Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses. Pathogens 2021;10:565. [PMID: 34066983 DOI: 10.3390/pathogens10050565] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
17 McGrowder DA, Miller F, Anderson Cross M, Anderson-Jackson L, Bryan S, Dilworth L. Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis. Diseases 2021;9:50. [PMID: 34287285 DOI: 10.3390/diseases9030050] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Yu D, Du Q, Yan S, Guo XG, He Y, Zhu G, Zhao K, Ouyang S. Liver injury in COVID-19: clinical features and treatment management. Virol J 2021;18:121. [PMID: 34108015 DOI: 10.1186/s12985-021-01593-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ozkurt Z, Çınar Tanrıverdi E. COVID-19: Gastrointestinal manifestations, liver injury and recommendations. World J Clin Cases 2022; 10(4): 1140-1163 [DOI: 10.12998/wjcc.v10.i4.1140] [Reference Citation Analysis]
20 Nardo AD, Schneeweiss-Gleixner M, Bakail M, Dixon ED, Lax SF, Trauner M. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int 2021;41:20-32. [PMID: 33190346 DOI: 10.1111/liv.14730] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Du M, Yang DS, Liu M, Liu J. COVID-19 and Liver dysfunction: Epidemiology, Association and Potential Mechanisms. Clin Res Hepatol Gastroenterol 2021;:101793. [PMID: 34428501 DOI: 10.1016/j.clinre.2021.101793] [Reference Citation Analysis]
22 Kumar P, Sharma M, Sulthana SF, Kulkarni A, Rao PN, Reddy DN. Severe Acute Respiratory Syndrome Coronavirus 2-related Acute-on-chronic Liver Failure. J Clin Exp Hepatol 2021;11:404-6. [PMID: 33398222 DOI: 10.1016/j.jceh.2020.12.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Madhu D, Sharma S, Agarwal A, Saraya A. Special Considerations in the Management of Autoimmune Hepatitis in COVID-19 Hotspots: A Review. J Clin Transl Hepatol 2021;9:568-75. [PMID: 34447687 DOI: 10.14218/JCTH.2021.00001] [Reference Citation Analysis]
24 Vaishnav M, Elhence A, Biswas S, Pathak P, Anand A, Sheikh S, Singh V, Maitra S, Goel A, Shalimar. The Outcome after Hospital Discharge in Cirrhosis is Not Worsened with COVID-19 Infection: A Propensity Score-matched Analysis. J Clin Exp Hepatol 2021. [PMID: 34840484 DOI: 10.1016/j.jceh.2021.11.009] [Reference Citation Analysis]
25 Díaz LA, Idalsoaga F, Cannistra M, Candia R, Cabrera D, Barrera F, Soza A, Graham R, Riquelme A, Arrese M, Leise MD, Arab JP. High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data. World J Gastroenterol 2020; 26(48): 7693-7706 [PMID: 33505145 DOI: 10.3748/wjg.v26.i48.7693] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
26 Sima AR. Hydroxychloroquine's Probable Protective Effect in Liver injury among the COVID-19 Patients. Middle East J Dig Dis 2021;13:80-1. [PMID: 34712444 DOI: 10.34172/mejdd.2021.209] [Reference Citation Analysis]
27 Wu ZH, Yang DL. A meta-analysis of the impact of COVID-19 on liver dysfunction. Eur J Med Res. 2020;25:54. [PMID: 33148326 DOI: 10.1186/s40001-020-00454-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
28 Gatti M, Turrini E, Raschi E, Sestili P, Fimognari C. Janus Kinase Inhibitors and Coronavirus Disease (COVID)-19: Rationale, Clinical Evidence and Safety Issues. Pharmaceuticals (Basel) 2021;14:738. [PMID: 34451835 DOI: 10.3390/ph14080738] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
29 El-megharbel SM, Qahl SH, Alaryani FS, Hamza RZ. Synthesis, Spectroscopic Studies for Five New Mg (II), Fe (III), Cu (II), Zn (II) and Se (IV) Ceftriaxone Antibiotic Drug Complexes and Their Possible Hepatoprotective and Antioxidant Capacities. Antibiotics 2022;11:547. [DOI: 10.3390/antibiotics11050547] [Reference Citation Analysis]
30 Saviano A, Wrensch F, Ghany MG, Baumert TF. Liver disease and COVID-19: from Pathogenesis to Clinical Care. Hepatology. 2020;. [PMID: 33332624 DOI: 10.1002/hep.31684] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
31 Kajal K, Premkumar M, Chaluvashetty SB, Bhujade H, Kulkarni AV. Point-of-Care Thoracic Ultrasonography in Patients With Cirrhosis and Liver Failure. Cureus 2021;13:e15559. [PMID: 34277182 DOI: 10.7759/cureus.15559] [Reference Citation Analysis]
32 Li X, Zhong X, Wang Y, Zeng X, Luo T, Liu Q. Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis. PLoS One 2021;16:e0250602. [PMID: 33939733 DOI: 10.1371/journal.pone.0250602] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
33 Bütikofer S, Lenggenhager D, Wendel Garcia PD, Maggio EM, Haberecker M, Reiner CS, Brüllmann G, Buehler PK, Gubler C, Müllhaupt B, Jüngst C, Morell B. Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19. Liver Int 2021. [PMID: 34018314 DOI: 10.1111/liv.14971] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
34 Lv Y, Zhao X, Wang Y, Zhu J, Ma C, Feng X, Ma Y, Zheng Y, Yang L, Han G, Xie H. Abnormal Liver Function Tests Were Associated With Adverse Clinical Outcomes: An Observational Cohort Study of 2,912 Patients With COVID-19. Front Med (Lausanne) 2021;8:639855. [PMID: 34179034 DOI: 10.3389/fmed.2021.639855] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Kumar K, Kulkarni A. Elevated Liver Chemistries in COVID-19-Is It Not a Concern? Am J Gastroenterol 2021;116:424. [PMID: 32947321 DOI: 10.14309/ajg.0000000000000914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Kumar D, Srivastava S, Rajnikant T, Dawra S, Tevatia M, Mukherjee R. Liver function tests in COVID 19: A retrospective record-based study from a tertiary care centre in urban Maharashtra, India. Medical Journal Armed Forces India 2022. [DOI: 10.1016/j.mjafi.2022.02.010] [Reference Citation Analysis]
37 Abeysekera KW, Karteszi H, Clark A, Gordon FH. Spontaneous portomesenteric thrombosis in a non-cirrhotic patient with SARS-CoV-2 infection. BMJ Case Rep 2020;13:e238906. [PMID: 33371000 DOI: 10.1136/bcr-2020-238906] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
38 Philips CA, Kakkar K, Joseph M, Yerol PK, Ahamed R, Rajesh S, Augustine P. Critically Ill COVID-19 Patient with Chronic Liver Disease - Insights into a Comprehensive Liver Intensive Care. J Clin Transl Hepatol 2021;9:576-86. [PMID: 34447688 DOI: 10.14218/JCTH.2020.00110] [Reference Citation Analysis]
39 [DOI: 10.1101/2020.10.22.20216317] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
40 Su HY, Hsu YC. Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives . World J Clin Cases 2021; 9(13): 2951-2968 [PMID: 33969082 DOI: 10.12998/wjcc.v9.i13.2951] [Reference Citation Analysis]
41 Elhence A, Vaishnav M, Biswas S, Chauhan A, Anand A, Shalimar. Coronavirus Disease-2019 (COVID-19) and the Liver. J Clin Transl Hepatol 2021;9:247-55. [PMID: 34007807 DOI: 10.14218/JCTH.2021.00006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Higuera-de la Tijera F, Servín-Caamaño A, Reyes-Herrera D, Flores-López A, Robiou-Vivero EJA, Martínez-Rivera F, Galindo-Hernández V, Chapa-Azuela O, Chávez-Morales A, Rosales-Salyano VH. Impact of liver enzymes on SARS-CoV-2 infection and the severity of clinical course of COVID-19. Liver Res 2021;5:21-7. [PMID: 33520337 DOI: 10.1016/j.livres.2021.01.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
43 Wu H, Liu S, Luo H, Chen M. Progress in the Clinical Features and Pathogenesis of Abnormal Liver Enzymes in Coronavirus Disease 2019. J Clin Transl Hepatol 2021;9:239-46. [PMID: 34007806 DOI: 10.14218/JCTH.2020.00126] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Minutolo A, Petrone V, Fanelli M, Iannetta M, Giudice M, Ait Belkacem I, Zordan M, Vitale P, Rasi G, Sinibaldi-Vallebona P, Sarmati L, Andreoni M, Malergue F, Balestrieri E, Grelli S, Matteucci C. High CD169 Monocyte/Lymphocyte Ratio Reflects Immunophenotype Disruption and Oxygen Need in COVID-19 Patients. Pathogens 2021;10:1639. [PMID: 34959594 DOI: 10.3390/pathogens10121639] [Reference Citation Analysis]
45 Wu ZH, Yang DL. A meta-analysis of the impact of COVID-19 on liver dysfunction. Eur J Med Res 2020;25:54. [PMID: 33148326 DOI: 10.1186/s40001-020-00454-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 10.0] [Reference Citation Analysis]
46 Gandotra A, Mehtani R, Premkumar M, Duseja A, De A, Mallik N, Durgadevi S, Das A, Kalra N. Invasive Pulmonary Aspergillosis and Tuberculosis complicated by Hemophagocytic Lymphohistiocytosis - Sequelae of COVID-19 in a Liver Transplant Recipient. J Clin Exp Hepatol 2021. [PMID: 34898957 DOI: 10.1016/j.jceh.2021.12.002] [Reference Citation Analysis]
47 Albadawy RM, Jadoon BA, Mogahed MM, Ibrahim ME, Essawy TS, Amin AMA, Abd-Elraouf MS, Elawady MA. The Impact of Comorbidities on the Outcomes of Egyptian COVID-19 Patients: A Follow-Up Study. J Environ Public Health 2021;2021:6662476. [PMID: 34239576 DOI: 10.1155/2021/6662476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Premkumar M, Kedarisetty CK. Cytokine Storm of COVID-19 and Its Impact on Patients with and without Chronic Liver Disease. J Clin Transl Hepatol 2021;9:256-64. [PMID: 34007808 DOI: 10.14218/JCTH.2021.00055] [Reference Citation Analysis]
49 D’Ardes D, Boccatonda A, Cocco G, Fabiani S, Rossi I, Bucci M, Guagnano MT, Schiavone C, Cipollone F. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship. World J Gastroenterol 2022; 28(11): 1102-1112 [DOI: 10.3748/wjg.v28.i11.1102] [Reference Citation Analysis]
50 Saber-Moghaddam N, Salari S, Hejazi S, Amini M, Taherzadeh Z, Eslami S, Rezayat SM, Jaafari MR, Elyasi S. Oral nano-curcumin formulation efficacy in management of mild to moderate hospitalized coronavirus disease-19 patients: An open label nonrandomized clinical trial. Phytother Res 2021. [PMID: 33389761 DOI: 10.1002/ptr.7004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
51 Nardo AD, Schneeweiss-Gleixner M, Bakail M, Dixon ED, Lax SF, Trauner M. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int. 2021;41:20-32. [PMID: 33190346 DOI: 10.1111/liv.14730] [Cited by in Crossref: 36] [Cited by in F6Publishing: 46] [Article Influence: 18.0] [Reference Citation Analysis]
52 Omar AS, Kaddoura R, Orabi B, Hanoura S. Impact of COVID-19 pandemic on liver, liver diseases, and liver transplantation programs in intensive care units. World J Hepatol 2021; 13(10): 1215-1233 [PMID: 34786163 DOI: 10.4254/wjh.v13.i10.1215] [Reference Citation Analysis]
53 Campos-Murguía A, Román-Calleja BM, González-Regueiro JA, Hurtado-Díaz-de-León I, Solís-Ortega AA, Flores-García NC, García-Juárez I, Ruiz-Margáin A, Macías-Rodríguez RU. Clinical perspectives, assessment, and mechanisms of metabolic-associated fatty liver disease in patients with COVID-19. World J Gastroenterol 2021; 27(33): 5502-5519 [PMID: 34588748 DOI: 10.3748/wjg.v27.i33.5502] [Reference Citation Analysis]
54 Phipps MM, Verna EC. Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic. Liver Transpl 2021;27:1312-25. [PMID: 34096188 DOI: 10.1002/lt.26194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Baroiu L, Lese AC, Stefanopol IA, Iancu A, Dumitru C, Ciubara AB, Bujoreanu FC, Baroiu N, Ciubara A, Nechifor A, Anghel L, Tatu AL. The Role of D-Dimers in the Initial Evaluation of COVID-19. TCRM 2022;Volume 18:323-35. [DOI: 10.2147/tcrm.s357214] [Reference Citation Analysis]
56 Gracia-Ramos AE, Jaquez-Quintana JO, Contreras-Omaña R, Auron M. Liver dysfunction and SARS-CoV-2 infection. World J Gastroenterol 2021; 27(26): 3951-3970 [PMID: 34326607 DOI: 10.3748/wjg.v27.i26.3951] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Raschi E, Caraceni P, Poluzzi E, De Ponti F. Baricitinib, JAK inhibitors and liver injury: a cause for concern in COVID-19? Expert Opin Drug Saf 2020;19:1367-9. [PMID: 32840116 DOI: 10.1080/14740338.2020.1812191] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
58 Sirinawasatien A, Chantarojanasiri T, Ekpanyapong S, Tivatunsakul N, Luvira V. Coronavirus disease 2019 gastrointestinal and liver manifestations in adults: A review. JGH Open 2021;5:1257-65. [PMID: 34816011 DOI: 10.1002/jgh3.12671] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Boretti A, Banik B. Modulation of Covid-19 cytokine storm by tocilizumab. J Med Virol 2021. [PMID: 34617604 DOI: 10.1002/jmv.27380] [Reference Citation Analysis]
60 Kulkarni AV, Vasireddy S, Sharma M, Reddy ND, Padaki NR. COVID-19 Masquerading as Autoimmune Hepatitis (AIH) Flare- The First Report. J Clin Exp Hepatol 2021. [PMID: 34539127 DOI: 10.1016/j.jceh.2021.09.007] [Reference Citation Analysis]
61 Padmaprakash K, Thareja S, Raman N, Sowmya Karantha C, Muthukrishnan J, Vardhan V. “Does Transaminitis Predict Severity and Mortality in COVID 19 Patients?”. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.01.004] [Reference Citation Analysis]
62 Salık F, Uzundere O, Bıçak M, Akelma H, Akgündüz M, Korhan Z, Kandemir D, Kaçar CK. Liver function as a predictor of mortality in COVID-19: A retrospective study. Ann Hepatol 2021;:100553. [PMID: 34624543 DOI: 10.1016/j.aohep.2021.100553] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Sterling RK, Shin D, Shin Y, French E, Stevens MP, Bajaj JS, DeWit M, Sanyal AJ. FIB-4 Predicts Need for Mechanical Ventilation in a Multi-ethnic National cohort of COVID-19. Hepatol Commun 2021. [PMID: 34222739 DOI: 10.1002/hep4.1737] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Chen C, Riyahi S, Prince M, Thomas C, RoyChoudury A, Browne WF, Sweeney E, Margolis DJ. Predictors of biliary intervention in patients hospitalized for COVID-19. Abdom Radiol (NY) 2022. [PMID: 35234995 DOI: 10.1007/s00261-022-03461-0] [Reference Citation Analysis]
65 Kleiner DE. Liver Biopsy Shines a Light on COVID-19-Related Liver Injury. Cell Mol Gastroenterol Hepatol 2021;11:881-2. [PMID: 33144089 DOI: 10.1016/j.jcmgh.2020.10.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Yang SJ, Wei TC, Hsu CH, Ho SN, Lai CY, Huang SF, Chen YY, Liu SJ, Yu GY, Dou HY. Characterization of Virus Replication, Pathogenesis, and Cytokine Responses in Syrian Hamsters Inoculated with SARS-CoV-2. J Inflamm Res 2021;14:3781-95. [PMID: 34408462 DOI: 10.2147/JIR.S323026] [Reference Citation Analysis]
67 Cai Y, Ye LP, Song YQ, Mao XL, Wang L, Jiang YZ, Que WT, Li SW. Liver injury in COVID-19: Detection, pathogenesis, and treatment. World J Gastroenterol 2021; 27(22): 3022-3036 [PMID: 34168405 DOI: 10.3748/wjg.v27.i22.3022] [Reference Citation Analysis]
68 Shousha HI, Afify S, Maher R, Asem N, Fouad E, Mostafa EF, Medhat MA, Abdalazeem A, Elmorsy H, Aziz MM, Mohammed RS, Ibrahem M, Elgarem H, Omran D, Hassany M, Elsayed B, Abdelaziz AY, El Kassas M. Hepatic and gastrointestinal disturbances in Egyptian patients infected with coronavirus disease 2019: A multicentre cohort study. World J Gastroenterol 2021; 27(40): 6951-6966 [PMID: 34790017 DOI: 10.3748/wjg.v27.i40.6951] [Reference Citation Analysis]
69 Aloisio E, Colombo G, Arrigo C, Dolci A, Panteghini M. Sources and clinical significance of aspartate aminotransferase increases in COVID-19. Clin Chim Acta 2021;522:88-95. [PMID: 34411557 DOI: 10.1016/j.cca.2021.08.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
70 Premkumar M, Kajal K, Kulkarni AV, Gupta A, Divyaveer S. Point-of-Care Echocardiography and Hemodynamic Monitoring in Cirrhosis and Acute-on-Chronic Liver Failure in the COVID-19 Era. J Intensive Care Med 2021;36:511-23. [PMID: 33438491 DOI: 10.1177/0885066620988281] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
71 Calapod OP, Marin AM, Onisai M, Tribus LC, Pop CS, Fierbinteanu-Braticevici C. The Impact of Increased Fib-4 Score in Patients with Type II Diabetes Mellitus on Covid-19 Disease Prognosis. Medicina (Kaunas) 2021;57:434. [PMID: 33946377 DOI: 10.3390/medicina57050434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Haghani M, Varamini P. Temporal evolution, most influential studies and sleeping beauties of the coronavirus literature. Scientometrics 2021;:1-46. [PMID: 34188334 DOI: 10.1007/s11192-021-04036-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Kalal CR, Joshi H, Kumar V, Gopal D, Rathod D, Shukla A, Gianchandani T, Bhatt C. Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India. J Clin Transl Hepatol 2021;9:878-88. [PMID: 34966651 DOI: 10.14218/JCTH.2020.00099] [Reference Citation Analysis]
74 Dahiya DS, Kichloo A, Albosta M, Pagad S, Wani F. Gastrointestinal implications in COVID-19. J Investig Med 2020;68:1397-401. [DOI: 10.1136/jim-2020-001559] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
75 Leowattana W. Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients. World J Virol 2021; 10(3): 86-96 [PMID: 34079691 DOI: 10.5501/wjv.v10.i3.86] [Reference Citation Analysis]
76 Horvath A, Lind T, Frece N, Wurzer H, Stadlbauer V. Risk stratification in hospitalized COVID-19 patients. J Hepatol 2021;75:740-2. [PMID: 33901573 DOI: 10.1016/j.jhep.2021.04.024] [Reference Citation Analysis]
77 Singh A, Premkumar M, Singh V. Liver injury in COVID-19 - The culprit may not be COVID-19! J Hepatol 2021;75:739-40. [PMID: 33753154 DOI: 10.1016/j.jhep.2021.03.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Garrido M, Pereira Guedes T, Alves Silva J, Falcão D, Novo I, Archer S, Rocha M, Maia L, Sarmento-Castro R, Pedroto I. Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19. GE Port J Gastroenterol 2021;158:1-12. [PMID: 34192127 DOI: 10.1159/000513593] [Reference Citation Analysis]
79 Simon TG, Hagström H, Sharma R, Söderling J, Roelstraete B, Larsson E, Ludvigsson JF. Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study. BMC Gastroenterol 2021;21:439. [PMID: 34814851 DOI: 10.1186/s12876-021-02017-8] [Reference Citation Analysis]
80 Howden CW, Loomba R. A Message from the Editors. Aliment Pharmacol Ther 2022;55:4-5. [PMID: 34907571 DOI: 10.1111/apt.16701] [Reference Citation Analysis]
81 Chen VL, Hawa F, Berinstein JA, Reddy CA, Kassab I, Platt KD, Hsu CY, Steiner CA, Louissaint J, Gunaratnam NT, Sharma P. Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19. Dig Dis Sci. 2020;. [PMID: 32980956 DOI: 10.1007/s10620-020-06618-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
82 Sodeifian F, Seyedalhosseini ZS, Kian N, Eftekhari M, Najari S, Mirsaeidi M, Farsi Y, Nasiri MJ. Drug-Induced Liver Injury in COVID-19 Patients: A Systematic Review. Front Med (Lausanne) 2021;8:731436. [PMID: 34616757 DOI: 10.3389/fmed.2021.731436] [Reference Citation Analysis]
83 Kayaaslan B, Guner R. COVID-19 and the liver: A brief and core review. World J Hepatol 2021; 13(12): 2013-2023 [DOI: 10.4254/wjh.v13.i12.2013] [Reference Citation Analysis]
84 Pozzobon FM, Perazzo H, Bozza FA, Rodrigues RS, de Mello Perez R, Chindamo MC. Liver injury predicts overall mortality in severe COVID-19: a prospective multicenter study in Brazil. Hepatol Int 2021;15:493-501. [PMID: 33534084 DOI: 10.1007/s12072-021-10141-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]